
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorzoxazone
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Senores Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Chlorzoxazone Tablets USP, 250 mg, a therapeutic equivalent version of Paraflex (Chlorzoxazone) is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal condition...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 05, 2021
Lead Product(s) : Chlorzoxazone
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Senores Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All